🇺🇸 FDA
Patent

US 10870645

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

granted A61PA61P19/02A61P25/28

Quick answer

US patent 10870645 (Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors) held by Valo Early Discovery, Inc. expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Valo Early Discovery, Inc.
Grant date
Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P19/02, A61P25/28, A61P35/00